Curosurf
Drug Neonatology
NDC 10122-510-01
General payments
$1,490,957
Research payments
$837,792
Through program year 2025, $1,490,957 in general payments and $837,792 in research payments were reported against Curosurf (Neonatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $372,014 | 585 |
| 2024 | General | $414,221 | 637 |
| 2023 | General | $277,963 | 594 |
| 2022 | General | $110,724 | 581 |
| 2022 | Research | $566,842 | 117 |
| 2021 | General | $63,566 | 482 |
| 2021 | Research | $270,950 | 43 |
| 2020 | General | $43,439 | 315 |
| 2019 | General | $209,030 | 689 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,883 general · 160 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.